|4Sep 5, 5:05 PM ET

Frelick Jeff 4

4 · Bone Biologics Corp · Filed Sep 5, 2023

Insider Transaction Report

Form 4
Period: 2023-08-31
Frelick Jeff
Chief Executive Officer
Transactions
  • Purchase

    Common Stock

    2023-08-31$0.66/sh+7,600$5,0207,704 total
Footnotes (1)
  • [F1]Includes 104 shares of vested restricted stock that were inadvertently reported in Table II at the time of grant.

Documents

1 file
  • 4
    ownership.xmlPrimary